ResMed | RMD - 市值

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 27.84B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	市值	更改		日
Ansell	USD 3.36B		450.92M	2025-12
Artivion	USD 2.18B		176M	2025-12
AtriCure	USD 1.44B		522M	2026-03
Baxter International	USD 8.67B		1.15B	2026-03
Cochlear	AUD 17.05B		2.6B	2025-12
Cooper Companies	USD 12.38B		105M	2026-06
CSL	USD 55.89B		20.42B	2025-12
Dexcom	USD 24.17B		1.72B	2026-03
Edwards Lifesciences	USD 46.17B		3.3B	2026-03
Fisher Paykel Healthcare	NZD 21.76B		2.1B	2025-12
Globus Medical	USD 11.69B		2M	2026-03
Idexx Laboratories	USD 44.63B		9.39B	2026-03
Insulet	USD 14.53B		5.46B	2026-03
Integra LifeSciences	USD 733M		234M	2026-03
Intuitive Surgical	USD 163.73B		37.04B	2026-03
Medtronic	USD 97.45B		9.53B	2026-06
Philips	EUR 22.47B		96.29M	2026-03
Ramsay Health Care	AUD 7.93B		537.83M	2025-12
ResMed	USD 32.7B		2.46B	2026-03
Sigma Healthcare	AUD 2.88B		1.8B	2026-06
Sonic Healthcare	AUD 11.17B		1.7B	2025-12
Steris	USD 21.69B		3.2B	2026-03
Teleflex	USD 5.3B		99M	2026-03
Thermo Fisher Scientific	USD 182.66B		35.04B	2026-03